Back to Search Start Over

ROR agonist hampers the proliferation and survival of postactivated CD8 + T cells through the downregulation of cholesterol synthesis-related genes.

Authors :
Cai Z
Ishibashi T
Kozai M
Mita H
Wang S
Takada K
Inaba M
Source :
Immunology and cell biology [Immunol Cell Biol] 2021 Mar; Vol. 99 (3), pp. 288-298. Date of Electronic Publication: 2020 Oct 25.
Publication Year :
2021

Abstract

Cholesterol is a major component of the lipid bilayers of cellular membranes. The synthesis of cholesterol is acutely elevated during T-cell activation to support T-cell growth and proliferation. There is a limited understanding of cholesterol metabolism reprogramming during T-cell activation. Retinoic acid receptor-related orphan receptors (RORs) are ligand-activated nuclear receptors that regulate the transcription of target genes. In this study, we demonstrated that the activation of RORs by a synthetic agonist (SR1078) impairs the proliferation and survival of postactivated CD8 <superscript>+</superscript> T cells. The inhibitory effects of SR1078 on CD8 <superscript>+</superscript> T-cell proliferation and survival were attributed to cholesterol depletion and downregulated expression of cholesterol metabolism-related genes. The overexpression of RORα or RORγt promoted apoptosis in the postactivated CD8 <superscript>+</superscript> T cells in vitro. The expression of RORα (but not that of RORγt) was markedly upregulated in the CD8 <superscript>+</superscript> T cells upon stimulation with an antigen in vivo. The functional deficiency of RORα enhanced CD8 <superscript>+</superscript> T-cell expansion during the response to bacterial infection. These results suggest that RORs are involved in the regulation of CD8 <superscript>+</superscript> T-cell-mediated immune response through the regulation of cholesterol metabolism, which can be modulated by a synthetic ROR agonist. The findings of this study can aid in the development of immunotherapeutic methods that target nuclear receptors.<br /> (© 2020 Australian and New Zealand Society for Immunology Inc.)

Details

Language :
English
ISSN :
1440-1711
Volume :
99
Issue :
3
Database :
MEDLINE
Journal :
Immunology and cell biology
Publication Type :
Academic Journal
Accession number :
32940916
Full Text :
https://doi.org/10.1111/imcb.12406